Cargando…
Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia
Pimonidazole is finding increasing use in histochemical analyses of hypoxia in tumours. Whether it can identify every hypoxic cell in a tumour, and whether the usual subjective criteria used to define ‘positive’ cells are optimal, are less certain. Therefore, our aim was to develop an objective flow...
Autores principales: | Olive, P L, Durand, R E, Raleigh, J A, Luo, C, Aquino-Parsons, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363410/ https://www.ncbi.nlm.nih.gov/pubmed/11076663 http://dx.doi.org/10.1054/bjoc.2000.1489 |
Ejemplares similares
-
Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver.
por: Arteel, G. E., et al.
Publicado: (1995) -
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
por: Ragnum, H B, et al.
Publicado: (2015) -
Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
por: Cobb, L. M., et al.
Publicado: (1990) -
Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters
por: Eastham, A M, et al.
Publicado: (1999) -
An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
por: Raleigh, J. A., et al.
Publicado: (1994)